Form IRANNOTICE GSK plc

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY

6. AVGO
7. SPCX
8. BJ
9. BABA
10. DE

March 3, 2025 11:17 AM EST

GSK plc

79 New Oxford Street

London

WC1A 1DG

T +44 (0)20 8047 5000

March 3, 2025

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen,

Re: Notice of disclosure filed in Securities Exchange Act Annual Report under Section 219 of the

Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities

Exchange Act

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section

13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that GSK plc has

made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended

December 31, 2024, which was filed with the Securities and Exchange Commission on March 3, 2025.

The disclosure can be found on page 300 of the 2024 Annual Report on Form 20-F, under the heading

“Section 13(r) of the Exchange Act”.

Respectfully submitted,

Registered in England & Wales

Company Number : 03888792

Registered Office : 79 New Oxford Street, London, WC1A 1DG

SEC Filings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!